Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and would not recommend the drug coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.

    Nalmefene Is Not “Just Like Naloxone”

    Opvee, an opioid-overdose antidote manufactured by Indivior that was approved in 2023, has in ...

    You Can Definitely Misuse Naloxone, If You’re a Cop

    Cops seem to have decided that ever since fentanyl came into the illicit drug ...

    WA Advances Fentanyl-Detecting K-9s—and Police Immunity From Damages

    Washington State has advanced a bill to train drug-sniffing dogs to detect fentanyl—and limit ...

    White House Issues Very Soft Call for Prisoner Access to OUD Meds

    The White House Office of National Drug Control Policy (ONDCP) released its first press ...

    The DEA Made a “Fentanyl Facts” Quiz. Let’s See How They Did.

    One of the weirder things to come out of the Drug Enforcement Administration (DEA) ...

    Stimulant Treatment Research Finally Uses Outcome Besides Abstinence

    To whatever degree harm reduction has gotten mainstreamed, it still hasn’t budged the meaning ...

    The FDA Draft Guidance for Stimulant Use Disorder Medication Is… Decent

    One of the reasons we have Food and Drug Administration-approved medications for opioid use ...

    SAMHSA’s National Drug Use Survey Has a Fentanyl Problem

    Up through 2021, the Substance Abuse and Mental Health Services Administration (SAMHSA) national drug ...